EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:
“EORTC is pleased to be participating in European Association of Nuclear Medicine (EANM) 2026 congress in Vienna.
Among the programme highlights are a joint symposium with the EANM Oncology and Theranostics Committee on generating clinical evidence for radioligand therapies, and a presentation by Winette van der Graaf on practical lessons from multinational academic trials across Europe.
We look forward to connecting with colleagues and partners throughout the congress.”
Winette van der Graaf, Founding member of Common Sense Oncology (CSO), added:
“The collaboration between European Association of Nuclear Medicine (EANM) and EORTC – European Organisation for Research and Treatment of Cancer is truly an example of win-win.
The expertise from two sides can help strengthening collaborations in the field of radioligand therapies and improve evidence generation, which is in the best interest of patients affected by cancer.”
